| Literature DB >> 27465560 |
D Duncker1, J Bauersachs2, C Veltmann2.
Abstract
In the majority of cases sudden cardiac death (SCD) is caused by ventricular tachyarrhythmia. Implantable cardioverter-defibrillators (ICD) represent an evidence-based and established method for prevention of SCD. For patients who do not fulfill the criteria for guideline-conform implantation of an ICD but still have an increased, e.g. transient risk for SCD, a wearable cardioverter-defibrillator (WCD) vest was developed to temporarily prevent SCD. Numerous studies have shown the safety and efficacy of the WCD, although there is still a gap in evidence concerning a reduction in overall mortality and improvement in prognosis. This article gives an overview on the currently available literature on WCD, the indications, potential risks and complications.Entities:
Keywords: Cardiomyopathy; Mortality; Risk stratification; Tachycardia, ventricular; Ventricular fibrillation
Mesh:
Year: 2016 PMID: 27465560 DOI: 10.1007/s00108-016-0110-2
Source DB: PubMed Journal: Internist (Berl) ISSN: 0020-9554 Impact factor: 0.743